Morning Overview on MSN
A new two-pill combo just slashed LDL cholesterol by 48.6% in a phase 3 trial — the sharpest drop ever logged without adding a statin to the mix
For the roughly 30 million American adults who have been told their cholesterol is too high but cannot stomach a statin, the ...
“As bempedoic acid and ezetimibe are already approved as a single-dose therapy, the development of an oral triple combination with different doses of a statin, will make it easier for physicians to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results